Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Mar;79(3):409–415. doi: 10.1111/j.1365-2249.1990.tb08104.x

Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.

K H Enssle 1, B Fleischer 1
PMCID: PMC1534940  PMID: 1690617

Abstract

Cytotoxic T lymphocytes (CTL) with the CD4+ phenotype that recognize major histocompatibility complex (MHC) class II antigens are detectable very frequently in cultures of human alloreactive or virus-specific T cells. The significance of these CD4+ CTL for an immune reaction in vivo is not clear. Since Epstein-Barr virus (EBV) transformed B cells express HLA-class I and class II antigens equally well both CD8+ and CD4+ CTL should be stimulated during an acute EBV infection. We analysed the MHC specificity and the phenotype of EBV-specific CTL from patients with infectious mononucleosis (IM). When tested directly without any previous culture, T cells from patients in the acute phase of IM showed specific MHC-restricted cytotoxicity against the autologous B cell line. Addition of a HLA class I specific monoclonal antibody (MoAb) but not of a HLA class II specific MoAb resulted in a complete blocking of the lytic activity. Cell sorting revealed that the entire cytotoxic activity was present in the CD8+ fraction whereas no specific CTL were detectable in the CD4+ fraction. The absence of cytotoxicity in CD4+ cells was not due to a lack of activation of these cells since both CD8+ and CD4+ cells were activated in situ, showing spontaneous growth in interleukin-2 (IL-2) and expressing the activation marker TP103. Frequency estimation revealed that 1/300-1/600 CD8+ but only 1/2000-1/4000 CD4+ T cells gave rise to a specific CTL colony after 10 days. If CD4+ colonies were tested repeatedly for cytotoxicity we found that CD4+ CTL acquired their cytotoxicity during in vitro culture. In addition, we isolated EBV-specific CD4+ T cell clones able to lyse their stimulator cells in the presence but not in the absence of lectin, even after a long period of culture. Taken together our results show that cytotoxicity mediated by CD4+ T cells does not play a role in an anti-viral immune response.

Full text

PDF
409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biddison W. E., Rao P. E., Talle M. A., Goldstein G., Shaw S. Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens. J Exp Med. 1982 Oct 1;156(4):1065–1076. doi: 10.1084/jem.156.4.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chen L. K., Mathieu-Mahul D., Sasportes M., Degos L., Bensussan A. What is a T-cell clone? Effect of rIFN on T-cell clone function and T-cell receptor gene rearrangement. Hum Immunol. 1986 Nov;17(3):214–223. doi: 10.1016/0198-8859(86)90273-9. [DOI] [PubMed] [Google Scholar]
  3. Enssle K. H., Wagner H., Fleischer B. Human mumps virus-specific cytotoxic T lymphocytes: quantitative analysis of HLA restriction. Hum Immunol. 1987 Feb;18(2):135–149. doi: 10.1016/0198-8859(87)90011-5. [DOI] [PubMed] [Google Scholar]
  4. Fleischer B. A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J Immunol. 1987 Mar 1;138(5):1346–1350. [PubMed] [Google Scholar]
  5. Fleischer B. Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture. Nature. 1984 Mar 22;308(5957):365–367. doi: 10.1038/308365a0. [DOI] [PubMed] [Google Scholar]
  6. Fleischer B. Activation of human T lymphocytes I. Requirements for mitogen-induced proliferation of antigen-specific T lymphocyte clones. Eur J Immunol. 1983 Dec;13(12):970–976. doi: 10.1002/eji.1830131204. [DOI] [PubMed] [Google Scholar]
  7. Fleischer B., Kreth H. W. Clonal analysis of HLA-restricted virus-specific cytotoxic T lymphocytes from cerebrospinal fluid in mumps meningitis. J Immunol. 1983 May;130(5):2187–2190. [PubMed] [Google Scholar]
  8. Fleischer B. Non-specific propagation of human antigen-dependent T lymphocyte clones. J Immunol Methods. 1988 May 9;109(2):215–219. doi: 10.1016/0022-1759(88)90245-1. [DOI] [PubMed] [Google Scholar]
  9. Gromo G., Geller R. L., Inverardi L., Bach F. H. Signal requirements in the step-wise functional maturation of cytotoxic T lymphocytes. Nature. 1987 Jun 4;327(6121):424–426. doi: 10.1038/327424a0. [DOI] [PubMed] [Google Scholar]
  10. Holzmann B., Johnson J. P. A beta-galactosidase linked immunoassay for the analysis of antigens on individual cells. J Immunol Methods. 1983 Jun 10;60(3):359–367. doi: 10.1016/0022-1759(83)90293-4. [DOI] [PubMed] [Google Scholar]
  11. Kabelitz D., Herzog W. R., Zanker B., Wagner H. Human cytotoxic T lymphocytes. I. Limiting-dilution analysis of alloreactive cytotoxic T-lymphocyte precursor frequencies. Scand J Immunol. 1985 Sep;22(3):329–335. doi: 10.1111/j.1365-3083.1985.tb01888.x. [DOI] [PubMed] [Google Scholar]
  12. Krensky A. M., Clayberger C., Reiss C. S., Strominger J. L., Burakoff S. J. Specificity of OKT4+ cytotoxic T lymphocyte clones. J Immunol. 1982 Nov;129(5):2001–2003. [PubMed] [Google Scholar]
  13. Kreth H. W., Kress L., Kress H. G., Ott H. F., Eckert G. Demonstration of primary cytotoxic T cells in venous blood and cerebrospinal fluid of children with mumps meningitis. J Immunol. 1982 Jun;128(6):2411–2415. [PubMed] [Google Scholar]
  14. Matsui Y., Staunton D. E., Shapiro H. M., Yunis E. J. Comparison of MHC antigen expression on PHA- and MLC-induced T cell lines with that on T and B lymphoblastoid cell lines by cell cycle dependency. Hum Immunol. 1986 Mar;15(3):285–301. doi: 10.1016/0198-8859(86)90004-2. [DOI] [PubMed] [Google Scholar]
  15. Misko I. S., Pope J. H., Hütter R., Soszynski T. D., Kane R. G. HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies. Int J Cancer. 1984 Feb 15;33(2):239–243. doi: 10.1002/ijc.2910330212. [DOI] [PubMed] [Google Scholar]
  16. Moretta L., Mingari M. C., Sekaly P. R., Moretta A., Chapuis B., Cerottini J. C. Surface markers of cloned human T cells with various cytolytic activities. J Exp Med. 1981 Aug 1;154(2):569–574. doi: 10.1084/jem.154.2.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Spits H., Ijssel H., Terhorst C., de Vries J. E. Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: isolation of clones that differ in phenotype and specificity. J Immunol. 1982 Jan;128(1):95–99. [PubMed] [Google Scholar]
  18. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 1981 Apr;126(4):1614–1619. [PubMed] [Google Scholar]
  19. Wallace L. E., Rickinson A. B., Rowe M., Epstein M. A. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature. 1982 Jun 3;297(5865):413–415. doi: 10.1038/297413a0. [DOI] [PubMed] [Google Scholar]
  20. Yasukawa M., Zarling J. M. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J Immunol. 1984 Jul;133(1):422–427. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES